TearScience^TM LipiFlow^TM Thermal Pulsation System

Designed to Improve Gland Function

The TearScience^TM LipiFlow^TM Thermal Pulsation System, is a medical device used by physicians in addressing Meibomian Gland Dysfunction (MGD). It consists of a Console and a single-use sterile device, known as the Activator, and has a drug-free mechanism of action. Eye care professionals use the TearScience^TM LipiFlow^TM System to treat MGD patients in-office with confidence and efficiency.

The TearScience^TM LipiFlow^TM System represents more than 14 years of dedicated research and is protected by more than 30 patents. A phased pressure profile with adaptive force equalization and proximal-to-distal peristaltic motion evacuates gland contents as the inner lid is gently heated.

How the TearScience^TM LipiFlow^TM System Works

• The procedure centers around the breakthrough Vectored Thermal Pulsation (VTP) Technology
  After an initial anesthetic drop, no drugs are required for the procedure
  As the only automated treatment for MGD, TearScience^TM LipiFlow^TM applies precise heat from the inner lid and pressure to remove gland obstructions while protecting delicate  structures of the eye²
  As a result, the obstructed meibum is liquefied and pushed up and out of the gland orifices
  Contoured design vaults the cornea and protects the eye
  Heat and pressure are regulated with redundant sensors

Key Messages for Patients

Did You Know?

• In one study, up to 86% of dry eye patients had signs of MGD³
  Approximately 1 in 5 patients with MGD are asymptomatic⁴
  TearScience^TM LipiFlow^TM has been shown to increase gland secretion threefold, on average, with just one treatment²
  Safety and long-term effectiveness have been demonstrated in peer-reviewed studies^5,6,7
  TearScience^TM LipiFlow^TM installations are evenly divided between ophthalmology and optometry clinics
  TearScience^TM LipiFlow^TM is available in more than 1500 practice locations in the United States and Canada as of January 2023